AAAAAA
Results: 1-25/29
Authors:
Mueck, AO
Seeger, H
Deuringer, FU
Wallwiener, D
Citation: Ao. Mueck et al., Effect of an estrogen/statin combination on biochemical markers of endothelial function in human coronary artery cell cultures, MENOPAUSE, 8(3), 2001, pp. 216-221
Authors:
Seeger, H
Wallwiener, D
Mueck, AO
Citation: H. Seeger et al., Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells, MENOPAUSE, 8(1), 2001, pp. 5-9
Authors:
Mueck, AO
Seeger, H
Wallwiener, D
Citation: Ao. Mueck et al., Further evidence for direct vascular actions of statins: Effect on endothelial nitric oxide synthase and adhesion molecules, EXP CL E D, 109(3), 2001, pp. 181-183
Authors:
Lippert, C
Seeger, H
Wallwiener, D
Mueck, AO
Citation: C. Lippert et al., The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment, EUR J GYN O, 22(5), 2001, pp. 331-335
Authors:
Mueck, AO
Seeger, H
Ludtke, R
Graser, T
Wallwiener, D
Citation: Ao. Mueck et al., Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest, MATURITAS, 38(3), 2001, pp. 305-313
Authors:
Mueck, AO
Citation: Ao. Mueck, Hormone replacement therapy in postmenopause - Ostrogen no protection for heart attack or stroke, GEBURTSH FR, 61(10), 2001, pp. 812-813
Authors:
Mueck, AO
Seeger, H
Lippert, TH
Citation: Ao. Mueck et al., Effect of transdermal versus oral estradiol substitution on the excretion of vasoactive markers in postmenopausal women, GYNAKOL GEB, 40(2), 2000, pp. 61-67
Authors:
Seeger, H
Mueck, AO
Lippert, TH
Citation: H. Seeger et al., Effects of valsartan and 17 beta-estradiol on the oxidation of low-densitylipoprotein in vitro, CORON ART D, 11(4), 2000, pp. 347-349
Authors:
Mueck, AO
Seeger, H
Wallwiener, D
Citation: Ao. Mueck et al., Fluvastatin combined with 17 beta-estradiol: Effect on the oxidation of human low density lipoprotein, EXP CL E D, 108(4), 2000, pp. 316-317
Authors:
Mueck, AO
Seeger, H
Lippert, C
Wallwiener, D
Citation: Ao. Mueck et al., Urinary excretion of vasoactive markers following estrogen replacement therapy in postmenopausal women, INT J CL PH, 38(8), 2000, pp. 381-386
Authors:
Seeger, H
Mueck, AO
Lippert, TH
Citation: H. Seeger et al., Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells, INT J CL PH, 38(5), 2000, pp. 270-272
Authors:
Lippert, TH
Mueck, AO
Seeger, H
Citation: Th. Lippert et al., Is the use of conjugated equine oestrogens in hormone replacement therapy still appropriate?, BR J CL PH, 49(5), 2000, pp. 489-490
Authors:
Seeger, H
Ludtke, R
Graser, T
Wallwiener, D
Mueck, AO
Citation: H. Seeger et al., Effect of oral contraceptives on the urinary excretion of biochemical markers indicating vasoactive action, J CLIN PH T, 25(3), 2000, pp. 221-226
Authors:
Lippert, TH
Seeger, H
Mueck, AO
Citation: Th. Lippert et al., The impact of endogenous estradiol metabolites on carcinogenesis, STEROIDS, 65(7), 2000, pp. 357-369
Authors:
Lippert, C
Seeger, H
Mueck, AO
Lippert, TH
Citation: C. Lippert et al., The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells, LIFE SCI, 67(13), 2000, pp. 1653-1658
Authors:
Seeger, H
Mueck, AO
Lippert, TH
Citation: H. Seeger et al., Effect of norethisterone acetate on estrogen metabolism in postmenopausal women, HORMONE MET, 32(10), 2000, pp. 436-439
Authors:
Lippert, TH
Seeger, H
Mueck, AO
Citation: Th. Lippert et al., Postmenopausal oestrogen administration: pharmacological treatment or substitution of the lacking hormone?, DEUT MED WO, 124(42), 1999, pp. 1245-1248
Authors:
Seeger, H
Mueck, AO
Oettel, M
Schwarz, S
Lippert, TH
Citation: H. Seeger et al., Calcium antagonistic effect of 17 alpha-estradiol derivatives: in vitro examinations, GYNECOL END, 13(4), 1999, pp. 246-248
Authors:
Mueck, AO
Seeger, H
Lippert, TH
Citation: Ao. Mueck et al., Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery, INT J CL PH, 37(7), 1999, pp. 365-366
Authors:
Lippert, TH
Mueck, AO
Citation: Th. Lippert et Ao. Mueck, Probing premarin, CAN MED A J, 161(11), 1999, pp. 1389-1390
Authors:
Lippert, C
Seeger, H
Wallwiener, D
Mueck, AO
Citation: C. Lippert et al., Effect of medroxyprogesterone acetate and norethisterone on the estradiol-stimulated proliferation of MCF-7 cells, MED SCI RES, 27(9), 1999, pp. 595-596
Authors:
Mueck, AO
Seeger, H
Lippert, TH
Citation: Ao. Mueck et al., Effect of valsartan and 17 beta-estradiol on proliferation of human vascular smooth muscle cells, MED SCI RES, 27(3), 1999, pp. 169-170
Authors:
Seeger, H
Lippert, C
Wallwiener, D
Mueck, AO
Citation: H. Seeger et al., Fluvastatin combined with 17 beta-estradiol and norethisterone: effect on the proliferation of smooth muscle cells from human coronary artery, MED SCI RES, 27(10), 1999, pp. 705-706
Authors:
Mueck, AO
Seeger, H
Lippert, TH
Citation: Ao. Mueck et al., Fluvastatin reduces endothelin secretion of cultured human umbilical vein endothelial cells, EUR J CL PH, 55(9), 1999, pp. 625-626
Authors:
Seeger, H
Mueck, AO
Lippert, TH
Citation: H. Seeger et al., Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures, LIFE SCI, 65(13), 1999, pp. PL167-PL170